Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE).
Ai Phuong TranDaniel TassoneJohannes Cornelis NossentNik Sheng DingPublished in: RMD open (2022)
ANZCTR: 12621000661875.